Sean McLoughlin - 31 Jan 2024 Form 4 Insider Report for HilleVax, Inc. (HLVX)

Reporting relationship: Chief Operating Officer
Issuer ticker: HLVX
Reported as of: 31 Jan 2024
Net transaction value: $0
SEC form: 4
Accepted by SEC: 02 Feb 2024, 16:05:15 UTC
Prior SEC filing: 26 Jan 2024
Next SEC filing: 01 Apr 2024
Source filing: View source filing
Reporting owner signature: /s/ Paul Bavier, Attorney-in-Fact for Sean McLoughlin

Key filing fact

Sean McLoughlin filed Form 4 for HilleVax, Inc. (HLVX) on 02 Feb 2024.

Key facts

This page summarizes Sean McLoughlin's Form 4 filing for HilleVax, Inc. (HLVX).
1 reported transaction and 1 derivative row are listed below.
Accepted by SEC: 02 Feb 2024, 16:05.

Change

Previous filing in this sequence was filed on 26 Jan 2024.
Current net transaction value: $0.

Research use

This tells you what this filing adds before you inspect full transaction and derivative tables.
You can trace every row back to the original SEC filing document.

Evidence

Filed on Form 4

Ownership activity is grounded in SEC Form 4 disclosures.

View source filing

Reported derivative securities

Options, warrants, convertible securities, or similar derivative positions disclosed in the filing.

HLVX transaction Derivative

Stock Option (Right to Buy)

Award

Transaction value: $0
Shares: +250,000
Change %
Price: $0.000000
Shares after: 250,000
Date: 31 Jan 2024
Ownership: Direct
Underlying class: Common Stock
Underlying amount: 250,000
Exercise price: $14.17
Footnotes: F1

^* marks a reported price that did not pass the local price check.

Additional SEC filing notes

Filing notes and footnotes

Explanation of responses 1 footnote

Footnote F1

The option is exercisable as it vests. The option will vest with respect to 25% of the shares of common stock on January 29, 2025, and will vest with respect to the remaining shares in equal monthly installments over the following three years subject to the reporting person's continuous service to the Issuer on the applicable vesting dates.